Mark Ball is a Plastic Surgeon and a Urologist in Bethesda, Maryland. Dr. Ball is rated as an Elite provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). His top areas of expertise are Von Hippel-Lindau (VHL) Syndrome, Renal Cell Carcinoma (RCC), Renal Oncocytoma, Nephrectomy, and Prostatectomy.

Dr. Thomas W. Jarrett has an expertise in minimally invasive surgery, including laparoscopic, robotic, ureteroscopic, percutaneous and image-guided therapies. Specifically, he has an expertise in percutaneous renal surgery, laparoscopic partial and radical nephrectomy, kidney stones, urinary tract reconstruction and kidney cancer. Dr. Jarrett earned his medical degree from Emory University School of Medicine, where he also completed his internship. He completed a residency in urology at New York Hospital, followed by a visiting fellowship in urology and ultrasonography in Salzburg, Austria. Dr. Jarrett completed his fellowship in endo-urology at Long Island Jewish Medical Center. He has previously served as the chief of the division of endourology and laparoscopy at the Johns Hopkins Hospital and the chief of the division of urology at Johns Hopkins Bayview Medical Center. Dr. Jarrett has been named a Top MD by Consumers’ Checkbook Magazine and a Top Doctor in the Washington D.C. and Washington-Baltimore areas by Castle Connolly. He has also been named a Super Doctor by the Washington Post. Dr. Jarrett is a member of the American Urological Association, the Society of Urologic Oncology and the Endourological Society. Dr. Jarrett has contributed to various publications and presentations on urology, earning him first prize in the World Congress of Endourology essay contest and the Faculty Research Award at Long Island Jewish Medical Center. He has editorial appointments at the Journal of Endourology and the Journal of Laparoendoscopic and Advanced Surgical Techniques. Dr. Jarrett is rated as a Distinguished provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). His top areas of expertise are Ureterocele, Renal Cell Carcinoma (RCC), Familial Wilms Tumor 2, Nephrectomy, and Ureteroscopy.

Dr. Mark Markowski is a medical oncologist at the Kimmel Cancer Center at Sibley Memorial Hospital, as well as an Associate Professor in the Department of Oncology at Johns Hopkins University School of Medicine. Dr. Markowski participates in multidisciplinary clinics at Sibley and The Johns Hopkins Hospital, and sees patients in the genitourinary clinics of both hospitals. Dr. Markowski treats numerous types of cancers, with a specialty in prostate and kidney cancers. Dr. Markowski earned his medical degree and Ph.D. in tumor biology at Georgetown University School of Medicine. He completed a residency in internal medicine at Columbia University, followed by a medical oncology fellowship at Johns Hopkins Hospital. Dr. Markowski previously served as a research associate at the Lombardi Comprehensive Cancer Center at Georgetown University. His research interests focus on early phase drug development for prostate cancer, as well a non-castrating therapies for patients with metastatic disease. Dr. Markowski is currently conducting research with funding from a Department of Defense Prostate Cancer Research Program Award and a Challenge Award from the Prostate Cancer Foundation, which focuses on new treatment strategies for prostate cancer patients. Dr. Markowski is rated as a Distinguished provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). His top areas of expertise are Prostate Cancer, Renal Cell Carcinoma (RCC), Wilms Tumor, Hormone Replacement Therapy (HRT), and Prostatectomy.

Andrew Akman, MD, MBA a native of Washington, DC, currently practices at Suburban Hospital, Sibley Hospital, and Johns Hopkins Hospital. Dr. Akman performs a variety of minimally invasive procedures. He has specific interest in complex IVC filter removals, interventional oncology, pulmonary embolism, and prostate artery embolization. Dr. Akman is an expert in complex IVC filter retrieval and IVC filter related complications. In addition to standard IVC filter retrievals, he removes devices that are severely tilted, embedded, or fractured, as well as those designated as permanent devices. He serves as an adviser to other physicians on complex techniques including laser sheath and forceps assisted retrieval. Within interventional oncology, Dr. Akman performs thermal ablation of lung, liver, and kidney tumors. He performs chemoembolization and radioembolization (Yttrium-90) on primary liver cancer and metastatic liver disease. Dr. Akman also performs prostate artery embolization, an emerging minimally invasive technique for treating urinary symptoms associated with prostate enlargement. Dr. Akman prides himself on building strong relationships with his patients and practicing patient-centered medicine. Videos Andrew Akman, M.D., Interventional Radiologist Recent News Articles and Media Coverage Honoring a Life By Helping Others, Johns Hopkins Medicine, (July 20, 2022). Dr. Akman is rated as an Advanced provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). His top areas of expertise are Ascites, Ureterocele, Familial Pancreatic Cancer, Gastrostomy, and Liver Embolization.

Armine Smith, M.D. is the director of urologic oncology at the Kimmel Cancer Center at Sibley Memorial Hospital, and an associate clinical professor of urology at the Brady Urological Institute of Johns Hopkins University School of Medicine. She is a member of Greenberg Bladder Cancer Institute and the director of Women's Bladder Cancer Program at Sibley Memorial Hospital. She is also a Mary and Armeane Choksi Scholar. Dr. Smith earned her medical degree from the University of California in San Francisco. She completed a residency in urology at the Cleveland Clinic, followed by a fellowship in urologic oncology at the National Cancer Institute, where she focused on development of personalized targeted therapies for bladder cancer. Dr. Smith is a member of the Society of Urologic Oncology, American Association of Cancer Research and American Urological Association. She has been selected multiple times as a Washington, DC and Virginia top urologist. Dr. Smith specializes in advanced open, minimally invasive and robotic urologic surgery for urologic malignancies, including bladder and upper tract urothelial cancer, kidney cancer, testicular cancer, penile and urethral cancer. In bladder cancer surgery she specializes in bladder preservation, complex urinary diversions, including continent orthotopic neobladder and continent catheterizable Indiana pouch techniques. In kidney cancer, her expertise focuses on partial nephrectomy, with the goal of oncologically-sound maximum nephron-sparing surgery. She has contributed to various research, publications and presentations on topics of urology. Dr. Smith has made TV appearances, lectured domestically and internationally, and authored chapters on urothelial and kidney cancer. Her current research focuses on elucidation of risk factors for bladder cancer development, oncologically safe organ preservation in both men and women with bladder and kidney cancer and improving outcomes from bladder cancer treatments. Listen to Dr. Smith’s Cancer Matters podcast episode to learn more about her work. Dr. Smith is rated as an Advanced provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). Her top areas of expertise are Bladder Cancer, Muscle Invasive Bladder Cancer, Urothelial Cancer, Cystectomy, and Reconstructive Urology Surgery.

Dr. Channing J. Paller is a medical oncologist at Sibley Memorial Hospital and a professor of oncology at the Johns Hopkins University School of Medicine. She practices out of the Prostate Cancer Multidisciplinary Clinic at Sibley Memorial Hospital in Washington, D.C., and the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins in Baltimore, MD. Dr. Paller has expertise in prostate, bladder, kidney, and testicular cancer. Dr. Paller earned her medical degree from Harvard Medical School and completed a residency in internal medicine, followed by a fellowship in hematology and oncology at Johns Hopkins University School of Medicine. In addition, Dr. Paller completed a rotation with the chief of the Investigational Drug Branch at the National Cancer Institute (NCI) Cancer Therapy Evaluation Program and a rotation with the associate director for regulatory science in the Office of Oncology Drug Products at the Food and Drug Administration. She also completed rotations at the Weizmann Institute of Israel’s Department of Biological Regulation and McCord Hospital in South Africa, where she participated in the Harvard AIDS project. In 2016, Dr. Paller was one of only five oncologists awarded the NCI Mentored Patient-Oriented Research Career Development Award. In 2015, she received the 2015 Passano Clinician Scientist Award for early-stage research that is already making a contribution to science. Earlier in her career, she was selected for both a 2011-2012 Young Investigator Award by the American Society of Clinical Oncology and for the 2011-12 Eastern Cooperative Oncology Group Paul Carbone Award. Dr. Paller is a member of the American Society of Clinical Oncology and the American Association for Cancer Research. Dr. Paller’s research focuses on evaluating new therapies for prostate cancer, particularly combination therapies that engage the immune system. She is the principal investigator on two multi-site clinical trials and was the first author on the NCI Investigational Drug Steering Committee publication, “Consensus Recommendations on the Phase I Combination Clinical Trials of the Clinical Trial Design Task Force.” Dr. Paller was the chair for the oral abstract session on genitourinary cancer at the 2015 Annual Meeting of the American Society of Clinical Oncology and she is currently funded by an NCI immunotherapy grant to look at combination therapies that link standard of care therapy with inhibition of transforming growth factor beta in prostate cancer. She is also opening trials of vitamin C with chemotherapy in prostate cancer and of mistletoe in all solid tumors. Dr. Paller is rated as an Advanced provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). Her top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Muscle Invasive Bladder Cancer, Hormone Replacement Therapy (HRT), and Prostatectomy.

Jonathan Rhee is a Urologist in Silver Spring, Maryland. Dr. Rhee is rated as an Experienced provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). His top areas of expertise are UPJ Obstruction, Bilateral Hydronephrosis, Hydronephrosis, Ureteroscopy, and Prostatectomy. Dr. Rhee is currently accepting new patients.

Kasey Morrison is a Urologist in Silver Spring, Maryland. Dr. Morrison has been practicing medicine for over 17 years and is rated as an Experienced provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). His top areas of expertise are Neurogenic Bladder, Bilateral Hydronephrosis, Hydronephrosis, Ureteroscopy, and Prostatectomy. Dr. Morrison is currently accepting new patients.

Sandeep Gurram is a Urologist in Bethesda, Maryland. Dr. Gurram is rated as a Distinguished provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). His top areas of expertise are Von Hippel-Lindau (VHL) Syndrome, Prostate Cancer, Renal Cell Carcinoma (RCC), Nephrectomy, and Prostatectomy.

Peter Pinto is a Urologist in Bethesda, Maryland. Dr. Pinto is rated as a Distinguished provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). His top areas of expertise are Prostate Cancer, Renal Cell Carcinoma (RCC), Enlarged Prostate (BPH), Prostatectomy, and Nephrectomy.

Dr. Kronthal joins the Johns Hopkins Community Radiology division from Drs. Groover, Christie and Merritt (GCM), where he has practiced at both Sibley and Suburban Hospitals for more than eleven years. He received his Bachelor of Arts at Haverford College in 1983 and medical degree at the University of Virginia in 1987. Dr. Kronthal performed both his radiology residency and Body Imaging fellowship at Johns Hopkins Hospital from 1998 through 1993. Following his fellowship, he spent twelve years with WBA Imaging, during which time he served as Chairman of the Department of Imaging at Prince George’s Hospital Center. Dr. Kronthal was with GCM from 2005 – 2017 and is the incoming Chairman of Radiology at Sibley Hospital. He is a past president of the District of Columbia Metropolitan Radiological Society. He was awarded fellowship in the American College of Radiology in 2005. Dr. Kronthal is rated as an Experienced provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). His top areas of expertise are Muscle Invasive Bladder Cancer, Pleurisy, Pleural Effusion, and ALK-Positive Non-Small Cell Lung Cancer.

Dr. Craig received his Bachelor’s degree from the U.S. Naval Academy, followed by medical school at The Uniformed Services University of the Health Sciences. During his career as a Navy radiologist, Dr. Craig served as Radiologic Consultant to the White House and Capitol Physician and as Chairman of Radiology at both Bethesda Naval Hospital and the Department of Radiologic Pathology at the Armed Forces Institute of Pathology where he was also section head of Genito-Urinary Imaging. Dr. Craig specializes in oncologic imaging and abdominal imaging with a focus on the genito-urinary system lecturing both nationally and internationally. He currently serves as Chairman of Radiology at Suburban Hospital, volunteers with the American Board of Radiology and is a journal reviewer for Radiographics. Dr. Craig is rated as an Experienced provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). His top areas of expertise are Collapsed Lung, Gallbladder Disease, Pleurisy, and Pleural Effusion.

Dr. Litvak received his undergraduate degree with distinction from the University of Michigan. He received his medical degree from the University of Maryland School of Medicine where he was honored with the Bradley A. Gaither Award for Excellence in Genitourinary Surgery. Dr. Litvak completed his residency in urological surgery at the Boston University School of Medicine where he served as chief resident. In 2005, Dr. Litvak joined Urological Consultants. Shortly thereafter he initiated the laparoscopic urology program at Suburban Hospital where he performed the first laparoscopic nephrectomy. In 2008, he and Dr. Radolinski initiated the Robotic Surgery program at Suburban Hospital. Dr. Litvak has published numerous journal articles and meeting abstracts on a wide array of urological topics. He has also authored several chapters in textbooks of urological surgery. He has taught courses in minimally invasive surgery both domestically and abroad. Dr. Litvak is honored to be recognized by his peers as one of the areas top urologists by receiving the Washingtonian Magazine’s Top Doctors Award. Dr. Litvak is rated as an Advanced provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). His top areas of expertise are Enlarged Prostate (BPH), Congenital Mesoblastic Nephroma, Obstructive Uropathy, Reconstructive Urology Surgery, and Nephrectomy.

Mark Goldstein is a Hematologist Oncology provider in Bethesda, Maryland. Dr. Goldstein is rated as an Experienced provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). His top areas of expertise are Childhood Iron Deficiency Anemia, Anal Cancer, Myelodysplastic Syndrome (MDS), and Pleuropulmonary Blastoma.

Dr. Kathleen Sterling is part of the Suburban Hospital’s medical staff and a urologist with Urological Consultants, P.A. Dr. Sterling served as chief resident of the University of Maryland Medical Center urology program. During her training, she performed laboratory research related to overactive bladder. With an undergraduate degree from Vanderbilt University, Dr. Sterling served as a Surface Warfare Officer in the United States Navy, completing two deployments at sea, including one combat mission during Operation Iraqi Freedom. Dr. Sterling treats both men and women. Her expertise includes voiding dysfunction, male and female urinary incontinence and female pelvic floor disorders. Dr. Sterling’s practice also encompasses medical and surgical management of kidney stones, erectile dysfunction and urological cancers. Dr. Sterling sees patients in Bethesda and Germantown, Maryland. For appointments, call 301-530-1700. Dr. Sterling is rated as an Experienced provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). Her top areas of expertise are Urinary Tract Infection in Children, Urinary Tract Infection (UTI), Urinary Incontinence, Kidney Stones, and Ureteroscopy.

Dr. Jones is a radiologist and currently serves as the Chief of Ultrasound at Sibley Memorial Hospital. He received his B.S. from Stanford University and Medical degree from the University of Wisconsin-Madison. He completed a diagnostic residency at the National Naval Medical Center, followed by a Cross-sectional Imaging fellowship at Georgetown University Hospital. Prior to joining Johns Hopkins, Dr. Jones was a staff radiologist at Suburban and Sibley Memorial Hospitals from 2004-2016. He serves as vice chairman of the Sibley Memorial Hospital Department of Radiology. Dr. Jones has subspecialty expertise in abdominal CT, MRI, ultrasound and image-guided biopsies. Dr. Jones is rated as an Experienced provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). His top areas of expertise are Collapsed Lung, Fecal Impaction, Pleurisy, and Pleural Effusion.

Bruce R. Kressel, M.D., is a medical oncologist at Johns Hopkins Kimmel Cancer Center at Sibley Memorial Hospital and an instructor at Johns Hopkins University School of Medicine. In addition to an expertise in breast and lung cancer, Dr. Kressel has an expertise in gynecologic oncology and general medical oncology, with specific focuses on hematologic malignancies including lymphoma, leukemia and myeloma. Dr. Kressel earned his medical degree at Tufts University School of Medicine. He completed a residency in internal medicine at George Washington University School of Medicine, followed by a fellowship in hematology and oncology, also at George Washington University School of Medicine. Dr. Kressel completed a fellowship in oncology at the Georgetown Lombardi Comprehensive Cancer Center as well. Dr. Kressel has been regularly named one of America’s Top Doctors and one of America's Top Doctors for Cancer by Castle Connolly. He has also been named a Top Doctor in the Washington D.C. and Washington-Baltimore areas by Castle Connolly, as well as a Top Doctor by Consumers’ Checkbook Magazine and Washingtonian Magazine. Dr. Kressel is a member of the American Society of Clinical Oncology and the American Society of Hematology. Dr. Kressel has contributed to numerous publications, presentations and clinical trials. Dr. Kressel is rated as an Experienced provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). His top areas of expertise are Essential Thrombocythemia, Non-Hodgkin Lymphoma, Gastric Lymphoma, Chronic Lymphocytic Leukemia (CLL), and Splenectomy.

Justin O. Benabdallah, M.D., is a urologist at Sibley Memorial Hospital, as well as an assistant professor of urology with the Brady Urological Institute and Department of Urology at Johns Hopkins Medicine. Dr. Benabdallah’s uses minimally invasive and robotic surgery techniques in the treatment of prostate and kidney cancer and has expertise in endourology for the treatment of kidney stones. He also specializes in men’s health, including erectile dysfunction, male infertility, vasectomy and enlarged prostate. Dr. Benabdallah earned his medical degree from Virginia Commonwealth University School of Medicine. He completed an internship and residency in urology at the Medical College of Wisconsin. Dr. Benabdallah also completed a fellowship in endourology and minimally invasive urology at Washington University School of Medicine in St. Louis, Missouri, where he served as a clinical instructor in urology. Dr. Benabdallah is a member of the American Urologic Society and the Endourology Society. Dr. Benabdallah earned the Dr. Anna Smither Award for Neurourology Research and the Housestaff Research Award from the Medical College of Wisconsin. Dr. Benabdallah has contributed to numerous publications and presentations on topics of urology. LinkedIn https://www.linkedin.com/in/justin-benabdallah-b827b3131 Videos Justin Benabdallah, M.D. Recent News Articles and Media Coverage Physicians taking the lead during 'Movember'. Fox 6 News. 11/30/2012. Dr. Benabdallah is rated as an Experienced provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). His top areas of expertise are Familial Prostate Cancer, Prostate Cancer, UPJ Obstruction, Ureteroscopy, and Nephrectomy.

Dr. Michael Pishvaian is the director of Gastrointestinal, Developmental Therapeutics and Clinical Research Programs for the Johns Hopkins Kimmel Cancer Center in the Greater Washington Area and an associate professor at the School of Medicine. Dr. Pishvaian is a fellowship-trained gastrointestinal oncologist specializing in pancreatic and refractory colorectal cancers. He is committed to precision medicine and provides his patients with the most appropriate and advanced level of care. He conducts all phases of clinical trials for all GI cancers and enrolls qualifying patients. Click here to learn more about oncology clinical trials the Greater Washington Area. Dr. Pishvaian is rated as an Experienced provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). His top areas of expertise are Pancreatic Cancer, Colorectal Cancer, Familial Pancreatic Cancer, Pancreaticoduodenectomy, and Pancreatectomy.

Dr. Frederick P. Smith is a medical oncologist specializing in breast cancer at Sibley Memorial Hospital and an instructor at Johns Hopkins School of Medicine and Georgetown University School of Medicine. He has a private practice in Washington, D.C. He is affiliated with Sibley Memorial Hospital and Suburban Hospital. Dr. Smith earned his medical degree from Saint Louis University School of Medicine. He completed a residency in internal medicine at Georgetown University Hospital, followed by a fellowship in oncology. Dr. Smith was named a 2012 Top Doctor in the Washington, D.C., Baltimore and Washington-Baltimore areas by Castle Connolly, as well as a Top MD by Consumers’ Checkbook Magazine. Prior to joining Johns Hopkins, Dr. Smith was the director of extramural oncology research at Georgetown University. In this position, he contributed over 50 articles to peer-reviewed medical journals. Dr. Smith is an integral advocate in the community for promoting access to clinical research. He has also contributed to clinical trials. Dr. Smith is rated as an Experienced provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). His top areas of expertise are Breast Cancer, Paget Disease of the Breast, Ovarian Carcinosarcoma, and Virilizing Ovarian Tumor.